Colorado PDAB First In Nation To Consider UPL For A Drug

By Luke Zarzecki / February 23, 2024 at 2:27 PM
Updated Story Colorado’s prescription drug affordability board (PDAB) voted unanimously Friday (Feb. 23) to consider establishing an upper payment limit on Amgen’s psoriasis and arthritis drug Enbrel, and if the board follows through it would be the first in the nation to establish an upper payment limit for a drug. PDAB Chair Gail Mizner noted that the vote means the board begins the process of setting a UPL, but the process can be stopped at any time...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.